NCT04574297

Brief Summary

To explore the impact on genetic and environmental factors for clinical manifestation, and the progression of chronic pancreatitis, including development of pancreatic insufficiency and other complications.

Trial Health

83
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
798

participants targeted

Target at P75+ for all trials

Timeline
56mo left

Started Jan 2011

Longer than P75 for all trials

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress77%
Jan 2011Dec 2030

Study Start

First participant enrolled

January 1, 2011

Completed
9.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2020

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

September 27, 2020

Completed
8 days until next milestone

First Posted

Study publicly available on registry

October 5, 2020

Completed
1.2 years until next milestone

Results Posted

Study results publicly available

November 30, 2021

Completed
9.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2030

Expected
Last Updated

November 30, 2021

Status Verified

October 1, 2021

Enrollment Period

9.4 years

First QC Date

September 27, 2020

Results QC Date

September 1, 2021

Last Update Submit

October 25, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • the Number of Patients Developing Pancreatic Insufficiency

    The primary endpoint was the number of patients developing pancreatic insufficiency, categorised as 1) diabetes and steatorrhea, 2) diabetes only, or 3) steatorrhea only.

    10 years

Secondary Outcomes (1)

  • Death

    20 years

Interventions

documenting the change of smoking and drinking status during the follow-up period

genetic sequencingDIAGNOSTIC_TEST

sequencing the susceptibility genes for CP, including serine protease inhibitor Kazal type 1, cationic trypsinogen, cystic fibrosis transmembrane conductance regulator, chymotrypsin C, etc.

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Consequent patients with a diagnosis of CP in Changhai Hospital between 2010 to 2014

You may qualify if:

  • patients with a diagnosis of chronic pancreatitis
  • agree to join the study and provide informed consent

You may not qualify if:

  • autoimmune pancreatitis
  • pancreatic cancer diagnosed within 2 years after the diagnosis of chronic pancreatitis
  • the follow-up time less than 2 years
  • patients presenting with diabetes and/or steatorrhea at onset of CP.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Ru N, Xu XN, Cao Y, Zhu JH, Hu LH, Wu SY, Qian YY, Pan J, Zou WB, Li ZS, Liao Z. The Impacts of Genetic and Environmental Factors on the Progression of Chronic Pancreatitis. Clin Gastroenterol Hepatol. 2022 Jun;20(6):e1378-e1387. doi: 10.1016/j.cgh.2021.08.033. Epub 2021 Aug 28.

Biospecimen

Retention: SAMPLES WITH DNA

The remained peripheral blood sample after laboratory examinations.

MeSH Terms

Conditions

Pancreatitis, ChronicTobacco SmokingAlcohol Drinking

Interventions

Smoking DevicesEthanol

Condition Hierarchy (Ancestors)

PancreatitisPancreatic DiseasesDigestive System DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsSmokingBehaviorTobacco UseDrinking Behavior

Intervention Hierarchy (Ancestors)

Manufactured MaterialsTechnology, Industry, and AgricultureAlcoholsOrganic Chemicals

Results Point of Contact

Title
Dr. Zhuan Liao
Organization
Changhai Hospital

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

September 27, 2020

First Posted

October 5, 2020

Study Start

January 1, 2011

Primary Completion

May 31, 2020

Study Completion (Estimated)

December 31, 2030

Last Updated

November 30, 2021

Results First Posted

November 30, 2021

Record last verified: 2021-10